Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:
Artificial Intelligence Commercial Coronavirus COVID-19

The Rise Of Digital – Deloitte Offers COVID-19 Recovery Strategies For Medtechs

  • Analysis

Executive Summary

Telemedicine and other digital tools should be a key part of post-pandemic coping strategies for medtech companies, says Deloitte.

You may also be interested in...



Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis

In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.

BIO Digital: Investment Panel Sees Continued Rising Adoption Of Telehealth, Remote Monitoring

BIO Digital investment panel sees strong investment opportunities in telehealth, remote monitoring and converging digital products.

Beyond COVID-19: Industry Insiders Offer 10 Strategies For Medtech Recovery

Medtech insiders offer 10 strategies for medtech companies to rethink their businesses right now.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight

Topics

Tags:
Artificial Intelligence Commercial Coronavirus COVID-19
UsernamePublicRestriction

Register

LL010986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By